CONNECT WITH US

Despite no Chinese anchor investors present at IPO, Arm CEO stated there's no differential treatment

Amanda Liang, Taipei; Jack Wu, DIGITIMES Asia 0

Credit: AFP

After completing the largest IPO of the US stock market in 2023, Arm, the IP giant under SoftBank, has entered a new phase of operations. How this will affect Arm's operations and company strategy in the Chinese market has the industry closely following,...

The article requires paid subscription. Subscribe Now